Viewing Study NCT01397734


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-01-08 @ 3:31 AM
Study NCT ID: NCT01397734
Status: TERMINATED
Last Update Posted: 2018-09-06
First Post: 2011-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Sponsor: Beth Israel Deaconess Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module